Netflix, Inc.
76.03USD
-0.7400 (-0.96%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.82▼ | $0.84 | 3 | 2 |
| Next quarter | $0.73▼ | $0.74 | 3 | 1 |
| Current year | $3.58▼ | $3.59 | 3 | 1 |
| Next year | $3.82▼ | $3.83 | 3 | 4 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.79 | $0.8 | +0.01 (+1.4%) |
| 2026-03-31 | $1.25 | $1.23 | -0.02 (-1.4%) |
| 2025-12-31 | $0.55 | $0.56 | +0.01 (+1.4%) |
| 2025-09-30 | $0.7 | $0.59 | -0.11 (-15.8%) |
953 ratings from 75 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wolfe Research | Maintained | Outperform | $84 $95 | Aug 25, 2026 |
| Baird | Maintained | Outperform | $120 $90 | Jul 22, 2026 |
| Goldman Sachs | Maintained | Buy | $110 $94 | Jul 17, 2026 |
| Piper Sandler | Maintained | Overweight | $115 $85 | Jul 17, 2026 |
| JP Morgan | Maintained | Overweight | $118 $85 | Jul 17, 2026 |
| Morgan Stanley | Maintained | Overweight | $90 $83 | Jul 17, 2026 |
| KGI Securities | Downgraded from Outperform | Neutral | $75 | Jul 17, 2026 |
| Oppenheimer | Maintained | Outperform | $100 $85 | Jul 17, 2026 |
| Rosenblatt | Maintained | Neutral | $95 $75 | Jul 17, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $105 $80 | Jul 17, 2026 |
| Evercore ISI Group | Maintained | Outperform | $115 $100 | Jul 17, 2026 |
| UBS | Maintained | Buy | $130 $115 | Jul 17, 2026 |
| Wedbush | Maintained | Outperform | $118 $105 | Jul 17, 2026 |
| Guggenheim | Maintained | Buy | $120 $75 | Jul 17, 2026 |
| Barclays | Maintained | Equal-Weight | $85 $80 | Jul 17, 2026 |
| TD Cowen | Maintained | Buy | $112 $100 | Jul 17, 2026 |
| Bernstein | Maintained | Outperform | $100 $95 | Jul 17, 2026 |
| Pivotal Research | Maintained | Hold | $96 $70 | Jul 17, 2026 |
| Guggenheim | Reiterated | Buy | $120 | Jul 15, 2026 |
| Morgan Stanley | Reiterated | Overweight | $115 $90 | Jul 14, 2026 |
| Rosenblatt | Maintained | Neutral | $95 | Jul 14, 2026 |
| Barclays | Maintained | Equal-Weight | $110 $85 | Jul 14, 2026 |
| Oppenheimer | Maintained | Outperform | $120 $100 | Jul 13, 2026 |
| Keybanc | Maintained | Overweight | $115 $92 | Jul 13, 2026 |
| Citigroup | Maintained | Buy | $115 $100 | Jul 9, 2026 |
163 filings from 21 insiders · 17 buy / 14 sell over 6m
Officers and directors of NFLX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BARTON RICHARD NDirector | ExerciseNon-Qualified Stock Option (right to buy) | 720 | — | — | Sep 8, 2026 |
| BARTON RICHARD NDirector | Sell | 720 | $77.60 | $56k | Sep 8, 2026 |
| BARTON RICHARD NDirector | Exercise | 720 | $20.11 | $14k | Sep 8, 2026 |
| BARTON RICHARD NDirector | GrantNon-Qualified Stock Option (right to buy) | 774 | — | — | Sep 1, 2026 |
| Dopfner MathiasDirector | GrantNon-Qualified Stock Option (right to buy) | 774 | — | — | Sep 1, 2026 |
| KILGORE LESLIE JDirector | GrantNon-Qualified Stock Option (right to buy) | 774 | — | — | Sep 1, 2026 |
| Masiyiwa StriveDirector | GrantNon-Qualified Stock Option (right to buy) | 774 | — | — | Sep 1, 2026 |
| MATHER ANNDirector | GrantNon-Qualified Stock Option (right to buy) | 774 | — | — | Sep 1, 2026 |
| Mertz ElinorDirector | GrantNon-Qualified Stock Option (right to buy) | 773 | — | — | Sep 1, 2026 |
| RICE SUSAN EDirector | GrantNon-Qualified Stock Option (right to buy) | 774 | — | — | Sep 1, 2026 |
| SMITH BRADFORD LDirector | GrantNon-Qualified Stock Option (right to buy) | 774 | — | — | Sep 1, 2026 |
| Karbowski Jeffrey WilliamOfficer, Chief Accounting Officer | GrantNon-Qualified Stock Option (right to buy) | 902 | — | — | Sep 1, 2026 |
| Hoag Jay CDirector | GrantNon-Qualified Stock Option (right to buy) | 774 | — | — | Sep 1, 2026 |
| NEUMANN SPENCER ADAMChief Financial Officer | Sell | 9.2k | $75.79 | $701k | Aug 10, 2026 |
| PETERS GREGORY K.Chief Executive Officer | Sell | 27.3k | $73.54 | $2.01M | Aug 6, 2026 |
| BARTON RICHARD NDirector | Sell | 2.2k | $75.10 | $162k | Aug 5, 2026 |
| BARTON RICHARD NDirector | Exercise | 2.2k | $20.11 | $43k | Aug 5, 2026 |
| HYMAN DAVID AOfficer | Sell | 5.7k | $72.85 | $417k | Aug 4, 2026 |
| SARANDOS THEODORE ANTHONY JR.Chief Executive Officer | Sell | 133.2k | $72.90 | $9.73M | Aug 4, 2026 |
| HYMAN DAVID AOfficer | Other | 11.4k | — | — | Aug 3, 2026 |
No analyst notes on NFLX yet.
Analyst Ratings
45 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 7 | 28 | 16 | 0 | 0 | Buy2.18 |
| 1 mo ago | 7 | 29 | 15 | 0 | 0 | Buy2.16 |
| 2 mo ago | 8 | 29 | 13 | 0 | 0 | Buy2.10 |